Is ballistic strength training more effective than usual care for improving mobility following traumatic brain injury (TBI)?
Not Applicable
Completed
- Conditions
- Traumatic Brain InjuryMobility LimitationsNeurological - Other neurological disordersPhysical Medicine / Rehabilitation - PhysiotherapyInjuries and Accidents - Other injuries and accidents
- Registration Number
- ACTRN12611001098921
- Lead Sponsor
- Epworth Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 131
Inclusion Criteria
Participants must have a neurologically based movement disorder affecting mobility as a result of TBI and be less than 12 months post injury.
Exclusion Criteria
- were unwilling or unable to provide informed consent
- have a previously diagnosed central nervous system disorder
- have severe cognitive or behavioural problems that prevent assessment
- have orthopaedic injuries restricting mobility
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High-Level Mobility Assessment Tool (HiMAT)[End of 12 week intervention phase<br>3 month follow-up]
- Secondary Outcome Measures
Name Time Method Self-selected walking speed[End of 12 week intervention phase<br>3 month follow-up];Balance - Single limb support time (left and right legs, eyes open and eyes closed)[End of 12 week intervention phase<br>3 month follow-up];Strength - 6RM seated leg press[End of 12 week intervention phase<br>3 month follow-up];Quality of Life (AQoL-6D)[End of 12 week intervention phase<br>3 month follow-up];Muscle Power Generation<br><br>Participants will be asked to perform a one-legged jump on their more-affected leg whilst lying on a reclined leg sled (LS). Participants will complete a series of five jumps at 50% of 1RM (as calculated during the muscle strength testing). The displacement occurring during each repetition will be recorded using a string potentiometer sampling at 200Hz, with data acquired via a customized LabVIEW software program (National Instruments, USA). [End of 12 week intervention phase and 3 month follow up ]